Anti-malarial Drugs Market Trends, Business Overview, Industry Growth and Forecast to 2028

The antimalarial drugs market accounted for $711,360 thousand in 2020 and is expected to reach $1,019,396 thousand by 2021, registering a CAGR of 4% from 2022 to 2028.

Malaria is an infectious disease, which spreads through a bite of infected female Anopheles mosquito, transferring parasites into the human body. Furthermore, these parasites lodge into liver cells where they multiply and grow. They then move to red blood cells to reach a stage called merozoites.

Key Players

• Merck KGaA
• Hoffmann-La Roche AG
• Novartis AG
• GlaxoSmithKline Plc
• Ranbaxy Laboratories
• Zydus Cadila

 

By Type

• Falciparum Malaria
• Vivax Malaria
• Others

 

By Application

• Machinery & Equipment
• Other

 

Scope of the Report

The research study analyses the Anti-malarial Drugs Market from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

 

Recent Developments

o Market Overview and growth analysis

o Import and Export Overview

o Volume Analysis

o Current Market Trends and Future Outlook

o Market Opportunistic and Attractive Investment Segment

 

Geographic Coverage 

o North America Market Size and/or Volume

o Latin America Market Size and/or Volume

o Europe Market Size and/or Volume

o Asia-Pacific Market Size and/or Volume

o Rest of the world Market Size and/or Volume

 

Key Questions Answered by Anti-malarial Drugs Market Report

• What was the Anti-malarial Drugs Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
• What will be the CAGR of the Anti-malarial Drugs Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Anti-malarial Drugs Market was the market leader in 2021?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.